Safety Study of a Helper Peptide Vaccine Plus Pembrolizumab
Clinical trial NCT02515227 · COMPLETED
Trial details
- NCT number
- NCT02515227
- Sponsor
- Craig L Slingluff, Jr
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-06
- Primary completion
- 2020-03-14
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.